Newborn screening: From Guthrie to whole genome sequencing

Public Health Reports

Volumn 128, Issue SUPPL. 2, 2013, Pages 14-19

  Caggana, Michele ^a   Jones, Elizabeth A ^b   Shahied, S I ^c   Tanksley, Susan ^d   Hermerath, Cheryl A ^e   Lubin, Ira M ^f  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b ASSOCIATION OF PUBLIC HEALTH LABORATORIES   (United States)

^c PENNSYLVANIA DEPARTMENT OF HEALTH   (United States)

^d TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^e Oregon State Public Health Laboratory   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL HEART DISEASE; CONGENITAL HYPOTHYROIDISM; CYSTIC FIBROSIS; DISABILITY; DNA SEQUENCE; DRIED BLOOD SPOT TESTING; FOLLOW UP; GALACTOSEMIA; GENE SEQUENCE; GENETIC PREDISPOSITION; GENOME; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTORY OF MEDICINE; HUMAN; MORBIDITY; MORTALITY; NEWBORN; NEWBORN SCREENING; NOTE; PHENYLKETONURIA; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SEVERE COMBINED IMMUNODEFICIENCY; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; TANDEM MASS SPECTROMETRY; ARTICLE; GENETIC MARKER; GENETICS; HISTORY; HUMAN GENOME; METHODOLOGY; NEWBORN DISEASE; UNITED STATES;

GENETIC MARKERS; GENOME, HUMAN; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NEONATAL SCREENING; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 84887377522     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549131280s204     Document Type: Note

References (40)

1. Ten great public health achievements-United States, 2001-2010. MMWR Morb Mortal Wkly Rep 2011;60(19):619-623.
2. American College of Medical Genetics and Genomics. September is National Newborn Screening Awareness Month. American College of Medical Genetics and Genomics strongly recommends new uniform panel of screening tests for all newborns in America [cited 2013 Feb 22]. Available from: URL: http://www.acmg.net/AM/TextTemplate.cfm?Section=Search2&template=/CM/HTMLDisplay.cfm&ContentID=1637
3. Lloyd-Puryear MA, Tonniges T, Van Dyck PC, Mann MY, Brin A, Johnson K, et al. American Academy of Pediatrics Newborn Screening Task Force recommendations: how far have we come? Pediatrics 2006;117(5 Pt 2):S194-S211.
4. Therrell BL, Adams J. Newborn screening in North America. J Inherit Metab Dis 2007;30:447-465.
5. MacCready RA, Hussey MG. Newborn phenylketonuria detection in Massachusetts. Am J Public Health Nations Health 1964;54:2075-2081.
6. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-343.
7. Van Dyck PC, Edwards ES. A look at newborn screening: today and tomorrow. Pediatrics 2006;117(5 Pt 2):S193.
8. National Research Council. Genetic screening: programs, principles, and research. Washington: National Academy of Sciences; 1975.
9. Serving the family from birth to the medical home. Newborn screening: a blueprint for the future-a call for a national agenda on state newborn screening programs. Pediatrics 2000;106(2 Pt 2):389-422.
10. Newborn screening: toward a uniform panel and system. Genet Med 2006;8 Suppl 1:1S-252S.
11. Therrell BL, Hannon WH. National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev 2006;12:236-245.
12. Department of Health and Human Services (US). Secretary's Advisory Committee on Heritable Disorders in Newborns and Children [cited 2013 Feb 22]. Available from: URL: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders
13. Perrin JM, Knapp AA, Browning MF, Comeau AM, Green NS, Lipstein EA, et al. An evidence development process for newborn screening. Genet Med 2010;12:131-134.
14. Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 2003;49:1797-1817.
15. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spec-trometry: a new method for acylcarnitine profling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-324.
16. Centers for Disease Control and Prevention (US). Newborn Screening Quality Assurance Program [cited 2013 Feb 22]. Available from: URL: http://www.cdc.gov/labstandards/nsqap.html
17. McCabe ER, Huang SZ, Seltzer WK, Law ML. DNA microextraction from dried blood spots on flter paper blotters: potential application for newborn screening. Hum Genet 1987;75:213-216.
18. Zhang YH, McCabe LL, Wilborn M, Therrell BL Jr, McCabe ER. Application of molecular genetics in public health: improved follow-up in a neonatal hemoglobinopathy screening program. Biochem Med Metab Biol 1994;52:27-35.
19. Clarke GM, Higgins TN. Laboratory investigation of hemoglobin-opathies and thalassemias: review and update. Clin Chem 2000;46(8 Pt 2):1284-1290.
20. Baker MW, Grossman WJ, Laessig RH, Hoffman JL, Brokopp CD, Kurtycz DF, et al. Development of a routine newborn screening protocol for severe combined immunodefciency. J Allergy Clin Immunol 2009;124:522-527.
21. Baker MW, Laessig RH, Katcher ML, Routes JM, Grossman WJ, Verbsky J, et al. Implementing routine testing for severe combined immunodefciency within Wisconsin's newborn screening program. Public Health Rep 2010;125(Suppl 2):88-95.
22. Association of Public Health Laboratories. Newborn screening molecular resources [cited 2013 Feb 22]. Available from: URL: http://www.aphl.org/aphlprograms/newborn-screening-and-genetics/molecular/pages/default.aspx
23. Millington DS, Sista R, Eckhardt A, Rouse J, Bali D, Goldberg R, et al. Digital microfuidics: a future technology in the newborn screening laboratory? Semin Perinatol 2010;34:163-169.
24. Eunice Kennedy Shriver National Institute of Child Health and Human Development National Human Genome Research Institute. Genomic sequencing and newborn screening disorders (U19) [cited 2013 Feb 22]. Available from: URL: http://grants.nih.gov/grants/guide/rfa-fles/RFA-HD-13-010.html
25. New York State Department of Health. Genetic testing and screening in the age of genomic medicine: executive summary. 2000 [cited 2013 Feb 22]. Available from: URL: http://www.health.ny.gov/regulations/task_force/reports_publications/screening.htm
26. Therrell BL Jr. Ethical, legal, and social issues in newborn screening in the United States. Southeast Asian J Trop Med Public Health 2003;34 Suppl 3:52-58.
27. Lewis MH, Goldenberg A, Anderson R, Rothwell E, Botkin J. State laws regarding the retention and use of residual newborn screening blood specimens. Pediatrics 2011;127:703-712.
28. Health Resources and Services Administration (US). Baby's first test: how screening works [cited 2013 Feb 22]. Available from: URL: http://www.babysfrsttest.org
29. Association of Public Health Laboratories. 50 years of saving babies' lives [cited 2013 Feb 22]. Available from: URL: http://www.aphl.org/aphlprograms/newborn-screening-and-genetics/50th-anniversary-of-newborn-screening/pages/default.aspx
30. Therrell BL, Hannon WH, Bailey DB Jr, Goldman EB, Monaco J, Norgaard-Pedersen B, et al. Committee report: considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet Med 2011;13:621-624.
31. Therrell BL Jr, Hannon WH. Newborn dried blood spot screening: residual specimen storage issues. Pediatrics 2012;129:365-6.
32. Therrell BL, Johnson A, Williams D. Status of newborn screening programs in the United States. Pediatrics 2006;117(5 Pt 2):S212-S252.
33. Michigan Department of Community Health. Michigan BioTrust for Health [cited 2013 Feb 22]. Available from: URL: http://www.michigan.gov/mdch/0,1607,7-132-2942_4911_4916-209738--,00.html
34. Newborn Screening Translational Research Network. Virtual repository of dried blood spots [cited 2013 Feb 22]. Available from: URL: https://www.nbstrn.org/research-tools/virtual-repository-of-dried-blood-spots
35. Beleno et al. v. Texas Department of State Health Services et al. (2009).
36. Higgins v. Texas Department of State Health Services et al. (2012).
37. Bearder et al. v. State of Minnesota (2011).
38. Offce of the Revisor of Statutes, State of Minnesota, Stat. 144.125.
39. Botkin JR, Clayton EW, Fost NC, Burke W, Murray TH, Baily MA, et al. Newborn screening technology: proceed with caution. Pediatrics 2006;117:1793-1799.
40. Routes JM, Grossman WJ, Verbsky J, Laessig RH, Hoffman GL, Brokopp CD, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA 2009;302:2465-2470.